Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 14.74 CAD 0.55% Market Closed
Market Cap: 377.2m CAD
Have any thoughts about
Cipher Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one CPH stock under the Base Case scenario is 11.86 CAD. Compared to the current market price of 14.74 CAD, Cipher Pharmaceuticals Inc is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPH Intrinsic Value
11.86 CAD
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cipher Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for CPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CPH?
Bearish
Neutral
Bullish

Fundamental Analysis

14.74 CAD
+0.55%
+0.55%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Cipher Pharmaceuticals Inc
CA
Pharmaceuticals
Market Cap
377.2m CAD
IPO
Feb 25, 2004
Employees
5
Canada
Market Cap
377.2m CAD
Industry
Pharmaceuticals
IPO
Feb 25, 2004
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cipher Pharmaceuticals Inc

Provide an overview of the primary business activities
of Cipher Pharmaceuticals Inc.

What unique competitive advantages
does Cipher Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Cipher Pharmaceuticals Inc face in the near future?

Summarize the latest earnings call
of Cipher Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cipher Pharmaceuticals Inc.

Provide P/S
for Cipher Pharmaceuticals Inc.

Provide P/E
for Cipher Pharmaceuticals Inc.

Provide P/OCF
for Cipher Pharmaceuticals Inc.

Provide P/FCFE
for Cipher Pharmaceuticals Inc.

Provide P/B
for Cipher Pharmaceuticals Inc.

Provide EV/S
for Cipher Pharmaceuticals Inc.

Provide EV/GP
for Cipher Pharmaceuticals Inc.

Provide EV/EBITDA
for Cipher Pharmaceuticals Inc.

Provide EV/EBIT
for Cipher Pharmaceuticals Inc.

Provide EV/OCF
for Cipher Pharmaceuticals Inc.

Provide EV/FCFF
for Cipher Pharmaceuticals Inc.

Provide EV/IC
for Cipher Pharmaceuticals Inc.

Show me price targets
for Cipher Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Cipher Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Cipher Pharmaceuticals Inc?

What are the Net Income projections
for Cipher Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Cipher Pharmaceuticals Inc?

What are the EPS projections
for Cipher Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Cipher Pharmaceuticals Inc?

What are the EBIT projections
for Cipher Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Cipher Pharmaceuticals Inc?

Compare the revenue forecasts
for Cipher Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cipher Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cipher Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cipher Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Cipher Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cipher Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Cipher Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Cipher Pharmaceuticals Inc.

Provide ROE
for Cipher Pharmaceuticals Inc.

Provide ROA
for Cipher Pharmaceuticals Inc.

Provide ROIC
for Cipher Pharmaceuticals Inc.

Provide ROCE
for Cipher Pharmaceuticals Inc.

Provide Gross Margin
for Cipher Pharmaceuticals Inc.

Provide Operating Margin
for Cipher Pharmaceuticals Inc.

Provide Net Margin
for Cipher Pharmaceuticals Inc.

Provide FCF Margin
for Cipher Pharmaceuticals Inc.

Show all solvency ratios
for Cipher Pharmaceuticals Inc.

Provide D/E Ratio
for Cipher Pharmaceuticals Inc.

Provide D/A Ratio
for Cipher Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Cipher Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Cipher Pharmaceuticals Inc.

Provide Quick Ratio
for Cipher Pharmaceuticals Inc.

Provide Current Ratio
for Cipher Pharmaceuticals Inc.

Provide Cash Ratio
for Cipher Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Cipher Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Cipher Pharmaceuticals Inc?

What is the current Free Cash Flow
of Cipher Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cipher Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cipher Pharmaceuticals Inc

Current Assets 29.1m
Cash & Short-Term Investments 9.5m
Receivables 13.2m
Other Current Assets 6.3m
Non-Current Assets 124.8m
PP&E 853k
Intangibles 101.7m
Other Non-Current Assets 22.3m
Current Liabilities 14.5m
Accounts Payable 5.5m
Accrued Liabilities 401k
Other Current Liabilities 8.6m
Non-Current Liabilities 40.5m
Long-Term Debt 40.5m
Efficiency

Earnings Waterfall
Cipher Pharmaceuticals Inc

Revenue
26.5m USD
Cost of Revenue
-5.1m USD
Gross Profit
21.4m USD
Operating Expenses
-11.5m USD
Operating Income
9.9m USD
Other Expenses
6m USD
Net Income
15.9m USD

Free Cash Flow Analysis
Cipher Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CPH Profitability Score
Profitability Due Diligence

Cipher Pharmaceuticals Inc's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Positive Gross Profit
Exceptional 3-Year Average ROE
79/100
Profitability
Score

Cipher Pharmaceuticals Inc's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

CPH Solvency Score
Solvency Due Diligence

Cipher Pharmaceuticals Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
66/100
Solvency
Score

Cipher Pharmaceuticals Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 20.43 CAD with a low forecast of 14.65 CAD and a high forecast of 31.5 CAD.

Lowest
Price Target
14.65 CAD
1% Downside
Average
Price Target
20.43 CAD
39% Upside
Highest
Price Target
31.5 CAD
114% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CPH?

Click here to dive deeper.

Dividends

Cipher Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one CPH stock?

The intrinsic value of one CPH stock under the Base Case scenario is 11.86 CAD.

Is CPH stock undervalued or overvalued?

Compared to the current market price of 14.74 CAD, Cipher Pharmaceuticals Inc is Overvalued by 20%.

Back to Top